Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Simcere Pharmaceutical Group...
Simcere Pharma has partnered with...
Simcere Pharma has filed an...
Simcere Pharma reported that Shanghai...
Simcere Pharma will receive a settlement...
Merck, known as MSD outside the US and Canada, announced...
Simcere Pharmaceutical will increase its...
Simcere Pharma reported that Biqi, the...
Simcere Pharma was granted SFDA approval...
Shanghai Fosun Pharma has purchased a 6.5% stake in...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China